INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE DE RENNES FILES APPLICATION FOR "COMBINATION OF A SLC16A1 INHIBITOR AND A SMAD3 INHIBITOR FOR TREATING CANCER"

GENEVA, Jan. 5 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), UNIVERSITE DE RENNES (Campus de Beaulieu263 avenue du General Leclerc35700 Rennes) filed a patent application (PCT/EP2025/067657) for "COMBINATION OF A SLC16A1 INHIBITOR AND A SMAD3 INHIBITOR FOR TREATING CANCER" on Jun 24, 2025. With publication no. WO/2026/002934, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PEDEUX, Remy (UMR1242 OSS INSERM - Universite de Rennes Centre de Lutte contre le Cancer Eugene Marqui...